Interdisciplinary intervention for the management of nonmedical opioid use among patients with cancer pain

Few studies have assessed interventions aimed at managing nonmedical opioid use (NMOU) behavior among patients with cancer. The authors developed the Compassionate High‐Alert Team (CHAT) intervention to manage patients receiving opioids for cancer pain who demonstrate NMOU behavior. The objective of this study was to determine the change in frequency of NMOU behaviors, pain intensity, and opioid requirements among those who received the intervention.

[1]  Aaron N. Winn,et al.  Opioid prescribing and use among cancer survivors: A mapping review of observational and intervention studies. , 2021, Journal of pain and symptom management.

[2]  E. Bruera,et al.  Prescription Opioids Dispensed to Patients with Cancer with Bone Metastasis: 2011-2017. , 2021, The oncologist.

[3]  E. Bruera,et al.  Managing nonmedical opioid use among patients with cancer pain during the COVID-19 Pandemic using the CHAT model and telehealth. , 2021, Journal of pain and symptom management.

[4]  E. Bruera,et al.  Frequency of and Factors Associated With Nonmedical Opioid Use Behavior Among Patients With Cancer Receiving Opioids for Cancer Pain. , 2021, JAMA oncology.

[5]  Diane D. Liu,et al.  Random urine drug testing among patients receiving opioid therapy for cancer pain , 2020, Cancer.

[6]  Michelle Walter,et al.  A Practical Approach to Non-Medical Opioid Use in Palliative Care Cancer Patients: Using the PARTNERS Framework. , 2020, Journal of pain and symptom management.

[7]  D. Walsh,et al.  Opioid Risk Screening in an Oncology Palliative Medicine Clinic. , 2020, JCO oncology practice.

[8]  J. Tsui,et al.  Identification and Management of Opioid Use Disorder in Primary Care: an Update , 2020, Current Psychiatry Reports.

[9]  E. Bruera,et al.  Random vs Targeted Urine Drug Testing Among Patients Undergoing Long-term Opioid Treatment for Cancer Pain. , 2020, JAMA oncology.

[10]  Joseph A Arthur.  Urine Drug Testing in Cancer Pain Management. , 2019, The oncologist.

[11]  Z. Sager,et al.  Navigating Challenging Conversations About Nonmedical Opioid Use in the Context of Oncology , 2019, The oncologist.

[12]  E. Bruera,et al.  Balancing opioid analgesia with the risk of nonmedical opioid use in patients with cancer , 2018, Nature Reviews Clinical Oncology.

[13]  Diane D. Liu,et al.  Predicting the risk for aberrant opioid use behavior in patients receiving outpatient supportive care consultation at a comprehensive cancer center , 2018, Cancer.

[14]  Diane D. Liu,et al.  Outcomes of a Specialized Interdisciplinary Approach for Patients with Cancer with Aberrant Opioid-Related Behavior. , 2018, The oncologist.

[15]  A. Rieber,et al.  Standardizing Opioid Prescribing Practices for Cancer-Related Pain Via a Novel Interactive Documentation Template at a Public Hospital. , 2017, Journal of oncology practice.

[16]  Diane D. Liu,et al.  Opioid Prescription Trends Among Patients With Cancer Referred to Outpatient Palliative Care Over a 6-Year Period. , 2017, Journal of oncology practice.

[17]  Diane D. Liu,et al.  Assessing the prognostic features of a pain classification system in advanced cancer patients , 2017, Supportive Care in Cancer.

[18]  Diane D. Liu,et al.  Frequency, predictors, and outcomes of urine drug testing among patients with advanced cancer on chronic opioid therapy at an outpatient supportive care clinic , 2016, Cancer.

[19]  M. Bennett,et al.  Opioid prescribing for patients with cancer in the last year of life: a longitudinal population cohort study , 2016, Pain.

[20]  E. Bruera,et al.  Minimal Clinically Important Difference in the Physical, Emotional, and Total Symptom Distress Scores of the Edmonton Symptom Assessment System. , 2016, Journal of pain and symptom management.

[21]  Emmanuela C. M. Obasi,et al.  Use of Palliative Care Services in a Tertiary Cancer Center , 2015, The oncologist.

[22]  D. Satre,et al.  Physician versus non-physician delivery of alcohol screening, brief intervention and referral to treatment in adult primary care: the ADVISe cluster randomized controlled implementation trial , 2015, Addiction Science & Clinical Practice.

[23]  E. Bruera,et al.  Minimal clinically important differences in the Edmonton Symptom Assessment Scale in cancer patients: A prospective, multicenter study , 2015, Cancer.

[24]  R. Arnold,et al.  Chronic Pain and Risk Factors for Opioid Misuse in a Palliative Care Clinic , 2015, The American journal of hospice & palliative care.

[25]  Diane D. Liu,et al.  Frequency, Predictors, and Medical Record Documentation of Chemical Coping Among Advanced Cancer Patients. , 2015, The oncologist.

[26]  S. Deandrea,et al.  Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  J. Kwon.  Overcoming barriers in cancer pain management. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  D. Anghelescu,et al.  Opioid misuse and abuse: risk assessment and management in patients with cancer pain. , 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

[29]  E. Bruera,et al.  Predictors of long-term opioid treatment among patients who receive chemoradiation for head and neck cancer. , 2013, The oncologist.

[30]  E. Bruera,et al.  Risk stratification of opioid misuse among patients with cancer pain using the SOAPP-SF. , 2013, Pain medicine.

[31]  T. Kwong,et al.  Urine drug testing for pain management. , 2012, Clinics in laboratory medicine.

[32]  Robert Taylor,et al.  Dynamic risk factors in the misuse of opioid analgesics. , 2012, Journal of psychosomatic research.

[33]  P. Stone,et al.  Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. , 2012, The Lancet. Oncology.

[34]  E. Bruera,et al.  Articles of interest in other scholarly journals , 2011, BMJ Supportive & Palliative Care.

[35]  J. Webber.  Center , 2011 .

[36]  Grant S. Fletcher,et al.  Strategies to implement alcohol screening and brief intervention in primary care settings: a structured literature review. , 2011, Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors.

[37]  K. Hammerstrøm,et al.  Motivational interviewing for substance abuse. , 2011, The Cochrane database of systematic reviews.

[38]  L. Manchikanti,et al.  Urine drug testing in chronic pain. , 2011, Pain physician.

[39]  Susan C. Daffron,et al.  A comparison of common screening methods for predicting aberrant drug-related behavior among patients receiving opioids for chronic pain management. , 2009, Pain medicine.

[40]  G. Rodin,et al.  Phase II study of an outpatient palliative care intervention in patients with metastatic cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  S. Passik,et al.  Pain and Aberrant Drug-Related Behaviors in Medically Ill Patients With and Without Histories of Substance Abuse , 2006, The Clinical journal of pain.

[42]  S. Butler,et al.  Validation of a screener and opioid assessment measure for patients with chronic pain , 2004, Pain.

[43]  V T Chang,et al.  Validation of the Edmonton Symptom Assessment Scale , 2000, Cancer.

[44]  P. Craft,et al.  Concurrent validity of the modified Edmonton Symptom Assessment System with the Rotterdam Symptom Checklist and the Brief Pain Inventory , 1998, Supportive Care in Cancer.

[45]  J. Stjernswärd,et al.  The World Health Organization Cancer Pain and Palliative Care Program. Past, present, and future. , 1996, Journal of pain and symptom management.

[46]  Eduardo Bruera,et al.  The Edmonton Symptom Assessment System (ESAS): A Simple Method for the Assessment of Palliative Care Patients , 1991, Journal of palliative care.

[47]  Dr. Beth Garcia,et al.  UNDOCUMENTED , 2019, International Journal of Humanities and Social Science.

[48]  Kelly C. Lee,et al.  Urine drug screening: practical guide for clinicians. , 2008, Mayo Clinic proceedings.

[49]  J. Stjernswärd.  WHO cancer pain relief programme. , 1988, Cancer surveys.